Literature DB >> 19696763

Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats.

Ana Alzamendi1, Daniel Castrogiovanni, Hugo H Ortega, Rolf C Gaillard, Andres Giovambattista, Eduardo Spinedi.   

Abstract

Hyperandrogenemia predisposes an organism toward developing impaired insulin sensitivity. The aim of our study was to evaluate endocrine and metabolic effects during early allostasis induced by a fructose-rich diet (FRD) in normal (control; CT) and neonatal-androgenized (testosterone propionate; TP) female adult rats. CT and TP rats were fed either a normal diet (ND) or an FRD for 3 weeks immediately before the day of study, which was at age 100 days. Energy intake, body weight (BW), parametrial (PM) fat characteristics, and endocrine/metabolic biomarkers were then evaluated. Daily energy intake was similar in CT and TP rats regardless of the differences in diet. When compared with CT-ND rats, the TP-ND rats were heavier, had larger PM fat, and were characterized by basal hypoadiponectinemia and enhanced plasma levels of non-esterified fatty acid (NEFA), plasminogen activator inhibitor-1 (PAI-1), and leptin. FRD-fed CT rats, when compared with CT-ND rats, had high plasma levels of NEFA, triglyceride (TG), PAI-1, leptin, and adiponectin. The TP-FRD rats, when compared with TP-ND rats, displayed enhanced leptinemia and triglyceridemia, and were hyperinsulinemic, with glucose intolerance. The PM fat taken from TP rats displayed increase in the size of adipocytes, decrease in adiponectin (protein/gene), and a greater abundance of the leptin gene. PM adipocyte response to insulin was impaired in CT-FRD, TP-ND, and TP-FRD rats. A very short duration of isocaloric FRD intake in TP rats induced severe metabolic dysfunction at the reproductive age. Our study supports the hypothesis that the early-androgenized female rat phenotype is highly susceptible to developing endocrine/metabolic dysfunction. In turn, these abnormalities enhance the risk of metabolic syndrome, obesity, type 2 diabetes, and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696763     DOI: 10.1038/oby.2009.255

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

1.  Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels.

Authors:  M Aslam; S V Madhu
Journal:  Endocrine       Date:  2017-09-06       Impact factor: 3.633

2.  Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats.

Authors:  Sanja Kovačević; Jelena Nestorov; Gordana Matić; Ivana Elaković
Journal:  Eur J Nutr       Date:  2014-01-14       Impact factor: 5.614

3.  Fructose rich diet-induced high plasminogen activator inhibitor-1 (PAI-1) production in the adult female rat: protective effect of progesterone.

Authors:  Daniel Castrogiovanni; Ana Alzamendi; Luisina Ongaro; Andrés Giovambattista; Rolf C Gaillard; Eduardo Spinedi
Journal:  Nutrients       Date:  2012-08-22       Impact factor: 5.717

4.  Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction.

Authors:  Ana Alzamendi; Andrés Giovambattista; María E García; Oscar R Rebolledo; Juan J Gagliardino; Eduardo Spinedi
Journal:  PPAR Res       Date:  2012-10-02       Impact factor: 4.964

5.  Oral metformin treatment prevents enhanced insulin demand and placental dysfunction in the pregnant rat fed a fructose-rich diet.

Authors:  Ana Alzamendi; Hector Del Zotto; Daniel Castrogiovanni; Jose Romero; Andres Giovambattista; Eduardo Spinedi
Journal:  ISRN Endocrinol       Date:  2012-08-16

6.  Impact of neonatal manipulation of androgen receptor function on endocrine-metabolic programming in the juvenile female rat.

Authors:  Luisina Ongaro; Andres Giovambattista; Eduardo Spinedi
Journal:  ISRN Endocrinol       Date:  2013-08-28

Review 7.  The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy.

Authors:  Eduardo Spinedi; Daniel P Cardinali
Journal:  Int J Endocrinol       Date:  2018-07-25       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.